Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept after Ciclosporin in Plaque Psoriasis
NCT00581555Phase 4Completed
- Sponsor
- Pfizer
- Start
- Oct 2007
- Primary completion
- Nov 2009
- Modality
- Fc-Fusion Proteins
01
Overview
Phase 4, randomised, double-blind trial in plaque psoriasis comparing Etanercept with Placebo (2 arms). Primary endpoint: Psoriasis Area and Severity Index at 24 weeks. Started Oct 2007; status: completed.
02
Drugs
etanercept
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT00581555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00581555.